The Franklin, Kentucky-based Blue Pharmaceuticals LLC has opened a new manufacturing facility in Dorado, Puerto Rico, this week that will manufacture ciprofloxacin, its anthrax antidote, among other pharmaceuticals. Read More…
iBio, Inc. has confirmed that its has granted rights for its iBioLaunch propietary technology to be used in support of a government-funded project developing a single vaccine to protect against both anthrax and plague. Read More…
The National Biodefense Science Board has recommended that a major effort be launched by the federal government to better focus its activities on developing medical countermeasures for biological, chemical, radiological and nuclear threats. Read More…
The Israeli Defense Ministry has been sued by 64 former soldiers for approximately $4.8 million over claims that they suffered damage from experiments in the early 1990s involving an anthrax vaccine. Read More…
Bavarian Nordic, a Danish biotechnology company, has announced that the FDA has decided that all requirements for delivery of the company’s smallpox vaccine to the United States government have been met. Read More…
Subscribe to get our free email newsletter and make changes to your subscription: